SanBio

SanBio’s stroke stem cell treatment receives innovation award from American Heart Association

Tuesday, February 28, 2017

SanBio, a provider of regenerative medicine for neurological disorders, announced that a recent publication of its novel stem cell treatment, SB623, for patients following a stroke, has received a prestigious award from the American Heart Association. The scientific article, “Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase I/IIa Study,” was the third prize winner of the 2016 Stroke Progress and Innovation Award.

[Read More]